SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Vertex Pharmaceuticals (VRTX) -- Ignore unavailable to you. Want to Upgrade?


To: Miljenko Zuanic who wrote (304)9/3/1999 12:24:00 AM
From: rkrw  Read Replies (1) | Respond to of 1169
 
I like your pseudonym (Sidney Street, not Miljenko).
For all of you, Vertex, Alkermes and a few other Cambridge based biotechs (MLNM, CBST) are located on Sidney Street. Its a biotech hub of Cambridge.

I am very pleased with the HMR renegotiation. Its quite a validation of Vertex and their ICE program. Seemingly HMR saw something they liked very much. It highlights that Vertex has plenty of good programs in place in addition to Agenerase.



To: Miljenko Zuanic who wrote (304)9/3/1999 8:01:00 PM
From: Sidney Street  Read Replies (1) | Respond to of 1169
 
CSFB = Credit Suisse First Boston, a pretty good pharma-biotech house. Alex To is the analyst and I have a vaguely positive impression of him - though I can't say where I've seen his stuff before.